Literature DB >> 18640768

Identification of high-risk prostate cancer: role of prostate-specific antigen, PSA doubling time, and PSA velocity.

Axel Heidenreich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640768     DOI: 10.1016/j.eururo.2008.06.077

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  6 in total

1.  The Optimal Application of Prostate-Specific Antigen (PSA) Velocity to Predict High-Risk Disease.

Authors:  Stacy Loeb; Anna Kettermann; Luigi Ferrucci; Patricia Landis; E Jeffrey Metter; Ballentine H Carter
Journal:  Eur Urol       Date:  2008-08-03       Impact factor: 20.096

2.  Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.

Authors:  Roopa Thapar; Mark A Titus
Journal:  Curr Metabolomics       Date:  2014-04

3.  A longitudinal study of PSA and its influential factors in a cohort of Chinese men with initial PSA levels less than 4 ng ml(-1).

Authors:  Ming Liu; Jian-Ye Wang; Hong-Xue Su; Gang Wan; Ling Zhu; Xiao-Ming Wang
Journal:  Asian J Androl       Date:  2013-06-10       Impact factor: 3.285

4.  The Effect of Exogenous Superoxide Dismutase (SOD) on Caspase-3 Activation and Apoptosis Induction in Pc-3 Prostate Cancer Cells.

Authors:  Jufriady Ismy; Suwandi Sugandi; Dedi Rachmadi; Sunaryo Hardjowijoto; Akhmad Mustafa
Journal:  Res Rep Urol       Date:  2020-10-27

5.  Optimising TNM Staging of Patients with Prostate Cancer Using WB-MRI.

Authors:  Vassiliki Pasoglou; Nicolas Michoux; Bertrand Tombal; Frédéric Lecouvet
Journal:  J Belg Soc Radiol       Date:  2016-11-19       Impact factor: 1.894

6.  [11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy.

Authors:  Sarah M Schwarzenböck; Anna Knieling; Michael Souvatzoglou; Jens Kurth; Katja Steiger; Matthias Eiber; Irene Esposito; Margitta Retz; Hubert Kübler; Jürgen E Gschwend; Markus Schwaiger; Bernd J Krause; Mark Thalgott
Journal:  Oncotarget       Date:  2016-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.